Physician profile
Robert A Light
NPI 1518919711
$6,306.81
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,769 · 2020: $441 · 2021: $697 · 2022: $400.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $2,159.32 | 2019-2022 | |
| Boston Scientific Corporation | $584.70 | 2019-2022 | |
| Janssen Biotech, INC. | $576.10 | 2019-2022 | |
| Astellas Pharma US INC | $451.14 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $393.39 | 2019-2020 | |
| Pfizer INC. | $290.16 | 2019-2020 | |
| Abbvie INC. | $259.11 | 2019-2022 | |
| Neotract INC. | $248.31 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $195.01 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $177.97 | 2019 | |
| Allergan, INC. | $119.36 | 2019-2021 | |
| Tolmar Pharmaceuticals, INC. | $117.96 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $99.82 | 2020-2021 | |
| Amgen INC. | $99.05 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $85.72 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $75.67 | 2019-2021 | |
| Antares Pharma, INC. | $54.13 | 2020-2021 | |
| Myriad Genetic Laboratories, INC. | $53.46 | 2021-2022 | |
| Convatec INC. | $40.00 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $37.87 | 2020 | |
| Blue Earth Diagnostics | $29.79 | 2021-2022 | |
| 180 Medical, INC. | $28.13 | 2020 | |
| Acerus Pharmaceuticals Corporation | $27.39 | 2020-2021 | |
| Axonics, INC. | $23.16 | 2020 | |
| Alexion Pharmaceuticals, INC. | $19.70 | 2022 | |
| Ambu INC. | $18.97 | 2021 | |
| Myovant Sciences INC. | $18.68 | 2021 | |
| Urogen Pharma, INC. | $14.20 | 2022 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Light listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.